• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Monthly Archive: March 2007

  • Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World
    • in Cardiovascular
    • — 27 Mar, 2007

    Audio Journal of Cardiovascular Medicine: “EXACT” Study: Carotid Stenting Benefits Are Maintained in the Real World

    William Gray

    WILLIAM GRAY, Columbia University, New York

    REFERENCE: Abstract 2409-5, American College of Cardiolgy New Orleans
    The benefits of carotid stenting as compared with surgery have been maintained in real-world settings since USA-approval of the technique in 2004, according to William
    …
    Read more
    Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering
    • in Cardiovascular
    • — 27 Mar, 2007

    Direct Renin Inhibitor Combined with Angiotensin Receptor Blockade Gives Additional Blood Pressure Lowering

    Suzanne Oparil

    SUZANNE OPARIL, University of Alabama, Birmingham

    REFERENCE: Abstract 405-12, American College of Cardiolgy New Orleans
    A combination of two antihypertensive agents has given improved blood pressure control in a study with nearly 2000 patients reported to the ACC meeting in
    …
    Read more
  • “RADIANCE-1” Study:  Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia
    • in Cardiovascular
    • — 27 Mar, 2007

    “RADIANCE-1” Study: Cholesteryl Ester Transfer Protein Inhibitor Fails to Benefit Patients with Familial Hypercholesterolemia

    John Kastelein

    JOHN KASTELEIN, Academic Medical Center, Amsterdam

    REFERENCE: Abstract 407-7, American College of Cardiolgy New Orleans
    A drug which raises HDL and reduces circulating levels of LDL has nevertheless failed to reduce atherosclerotic progression in patients with familial hypercholesterolemia. This disappointing
    …
    Read more
    “ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes
    • in Cardiovascular
    • — 27 Mar, 2007

    “ERASE” Trial: Infusions of Reconstituted HDL Treat Atherosclerosis in Patients with Acute Coronary Syndromes

    Jean-Claude Tardif

    JEAN-CLAUDE TARDIF, Montreal Heart Institute

    REFERENCE: Abstract 405-10, American College of Cardiolgy New Orleans
    Improvements in atheroma plaque have been achieved by infusing patients who have acute coronary syndromes with reconstituted high density lipoprotein, HDL, according to investigators from the
    …
    Read more
  • COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk
    • in Cardiovascular
    • — 26 Mar, 2007

    COURAGE Trial: Optimal Medical Therapy Alone is Sufficient for Patients with Stable Angina: Adding PCI Does Not Help – ILLUSTRATE Study Shows Torcetrapib Raises HDL But Fails to Lower Coronary Risk

    Steven Nissen

    STEVEN NISSEN, Cleveland Clinic, OH

    REFERENCE: N Engl J Med 2007 356
    Reporting from: American College of Cardiolgy New Orleans

    Two big studies published in the New England Journal of Medicine and presented simultaneously at the American College of Cardiology
    …
    Read more
    Bioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results
    • in Cardiovascular
    • — 26 Mar, 2007

    Bioabsorbable Everolimus-Eluting Stent: 6-Month Angiographic and IVUS Results

    Patrick Serruys
    Patrick Serruys

    Spencer King
    Spencer King

    PATRICK SERRUYS, Erasmus University, Rotterdam
    COMMENT: SPENCER KING, Piedmont Hospital, Atlanta

    REFERENCE: Abstract 2402-3, American College of Cardiology New Orleans
    Six-months follow-up of patients receiving a new bioabsorbable drug-eluting stent are favourable, according to Patrick Serruys
    …
    Read more
  • Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction
    • in Cardiovascular
    • — 26 Mar, 2007

    Increased Use of Recommended Drugs Explains Improved Trends in Prognosis after Myocardial Infarction

    Soko Setoguchi
    Soko Setoguchi

    Douglas Zipes
    Douglas Zipes

    SOKO SETOGUCHI, Brigham And Women’s Hospital, Boston
    COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis

    REFERENCE: Abstract 1018-148, American College of Cardiology New Orleans
    The increased adherence to recommendations and guidelines for drug therapy after myocardial infarction
    …
    Read more
    Rapid Genotype Assay for Individualized Warfarin Dosing
    • in Cardiovascular
    • — 25 Mar, 2007

    Rapid Genotype Assay for Individualized Warfarin Dosing

    Jeffrey Anderson
    Jeffrey Anderson

    Douglas Zipes
    Douglas Zipes

    JEFFREY ANDERSON, University of Utah, Salt Lake City
    COMMENT: DOUGLAS ZIPES, University of Indiana, Indianapolis

    REFERENCE: Abstract 1020-89, American College of Cardiology New Orleans
    The hope of refining treatments for cardiovascular disease by genotyping patients to
    …
    Read more
  • Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?
    • in Cardiovascular
    • — 25 Mar, 2007

    Thrombin Receptor Antagonist: Advantages in Percutaneous Coronary Intervention?

    David Moliterno

    DAVID MOLITERNO, University of Kentucky, Lexington

    REFERENCE: American College of Cardiolgy New Orleans, March 24th Late Breaking Trials
    An oral thrombin receptor antagonist, SCH 530348 has proved safe and effective, and may be better than conventional anti-coagulation treatments for patients
    …
    Read more
    When Good Cells Go Bad: The Stem Cell Origin of Cancers
    • in ASCO · Oncology
    • — 16 Mar, 2007

    When Good Cells Go Bad: The Stem Cell Origin of Cancers

    David Jablons

    DAVID JABLONS, University of California, San Francisco

    REFERENCE: Keynote Lecture, Perspectives in Lung Cancer Conference, 2-3 March 2007, Seville, Spain
    Cell signalling using the Wnt pathway may hold the key to many, if not all, the genetic pathways to cancer,
    …
    Read more
  • 6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates
    • in Public Health
    • — 15 Mar, 2007

    6 Months Exclusive Breast Feeding for Mothers with HIV Lowers Transmission Rates

    Hoosen Coovadia

    HOOSEN COOVADIA, University of KwaZulu-Natal, Durban

    REFERENCE: Abstract 13, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    In the developing world breastfeeding is the recommended infant feeding method, even for women infected with HIV. While early
    …
    Read more
    Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety
    • in Public Health
    • — 13 Mar, 2007

    Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety

    Howard Mayer

    Mark Wainberg

    HOWARD MAYER, Pfizer Global Research, New London CT
    MARK WAINBERG, McGill University, Montreal

    Abstract Number: 104aLB, 104bLB, 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles February 25-28, 2007
    In a population of treatment-experienced HIV-infected subjects, maraviroc plus optimised background
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • 2007
  • March

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.